Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 116.92 USD -0.62%
Market Cap: 203.4B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Abbott Laboratories
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbott Laboratories
Accrued Liabilities Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Accrued Liabilities
$6.5B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
6%
Becton Dickinson and Co
NYSE:BDX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Accrued Liabilities
$2.3B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
7%
Edwards Lifesciences Corp
NYSE:EW
Accrued Liabilities
$763m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Accrued Liabilities
$3.5B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
3%
Intuitive Surgical Inc
NASDAQ:ISRG
Accrued Liabilities
$867.5m
CAGR 3-Years
21%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Abbott Laboratories's Accrued Liabilities?
Accrued Liabilities
6.5B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Accrued Liabilities amounts to 6.5B USD.

What is Abbott Laboratories's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
6%

Over the last year, the Accrued Liabilities growth was -5%. The average annual Accrued Liabilities growth rates for Abbott Laboratories have been -1% over the past three years , 4% over the past five years , and 6% over the past ten years .

Back to Top